Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.17 USD | +5.78% | +6.28% | -48.09% |
Financials (USD)
Sales 2024 * | 440M | Sales 2025 * | 464M | Capitalization | 388M |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | -77M | EV / Sales 2024 * | 0.67 x |
Net cash position 2024 * | 92.26M | Net cash position 2025 * | 81.38M | EV / Sales 2025 * | 0.66 x |
P/E ratio 2024 * |
-4.57
x | P/E ratio 2025 * |
-5.04
x | Employees | 1,215 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.78% |
Latest transcript on Nevro Corp.
1 day | +5.78% | ||
1 week | +9.94% | ||
Current month | +5.58% | ||
1 month | -10.57% | ||
3 months | -34.83% | ||
6 months | -34.60% | ||
Current year | -48.09% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Thornal
CEO | Chief Executive Officer | 50 | 23-04-23 |
D. Grossman
CHM | Chairman | 63 | 19-03-18 |
Roderick MacLeod
DFI | Director of Finance/CFO | 57 | 20-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael DeMane
BRD | Director/Board Member | 67 | 11-03-16 |
Karen Prange
BRD | Director/Board Member | 60 | 19-12-16 |
D. Grossman
CHM | Chairman | 63 | 19-03-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 11.17 | +5.78% | 528,952 |
24-05-15 | 10.56 | +6.88% | 589,785 |
24-05-14 | 9.88 | -3.04% | 487,090 |
24-05-13 | 10.19 | +4.09% | 630,592 |
24-05-10 | 9.79 | -6.85% | 675,287 |
Delayed Quote Nyse, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.09% | 388M | |
-4.72% | 182B | |
+3.96% | 112B | |
-2.93% | 68.58B | |
+6.30% | 51.58B | |
+8.02% | 44.24B | |
+9.45% | 43.65B | |
+26.18% | 32.46B | |
+20.94% | 25.99B | |
+0.57% | 25.61B |
- Stock Market
- Equities
- NVRO Stock